- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Continuation of insulin glargine
Total 2705 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Saudi Arabia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Bosnia and Herzegovina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesBelgium, Luxembourg
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNetherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJordan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSouth Africa
-
SanofiCompletedType 2 Diabetes MellitusJapan
-
GeropharmCompletedClamp StudyRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFinland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesCanada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Delivery SystemsIndonesia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIsrael
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, United Kingdom, Spain, Denmark, France, Netherlands, Austria, Hungary, Russian Federation, Germany, Turkey, Italy, Bulgaria, Romania, Belgium, Switzerland, Slovenia, Czech Republic
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Taiwan, Korea, Republic of
-
University of Texas Southwestern Medical CenterNovo Nordisk A/STerminatedType 1 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovenia
-
Eli Lilly and CompanyCompleted
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNorway, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTunisia
-
Emory UniversityBoston Medical Center; Rush University; University of DenverCompleted
-
SanofiCompleted
-
WockhardtCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesHungary
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania
-
Novo Nordisk A/SCompletedObservational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (INTENSIV)Diabetes Mellitus, Type 2 | DiabetesAustria
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Italian Sarcoma GroupPharmaMarWithdrawnLeiomyosarcoma | Liposarcoma | Synovial SarcomaItaly
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Hungary, Slovakia, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesArgentina, Brazil
-
Baylor College of MedicineCompleted
-
Shanghai Cell Therapy Group Co.,LtdShanghai Mengchao Cancer HospitalNot yet recruiting
-
Inova Health Care ServicesWithdrawn
-
Merck Sharp & Dohme LLCCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFormer Serbia and Montenegro
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Former Serbia and Montenegro
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Emory UniversityCompleted
-
GeropharmCompletedBioequivalenceRussian Federation
-
Shahid Gangalal National Heart CentreKathmandu University School of Medical SciencesCompletedClinical Audit | Package of Essential Non-Communicable Diseases (PEN) | Peer Coaching | Mixed Method Implementation StudyNepal